The Technical Analyst
Progyny Inc [PGNY]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Progyny Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-0.79% $32.34
America/New_York / 25 apr 2024 @ 11:54
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 121.18 mill |
| EPS: | 0.620 |
| P/E: | 52.17 |
| Earnings Date: | May 06, 2024 |
| SharesOutstanding: | 96.50 mill |
| Avg Daily Volume: | 0.846 mill |
| RATING 2024-04-24 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 52.17 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 52.17 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$59.79 (84.87%) $27.45 |
| Date: 2024-04-25 |
| Expected Trading Range (DAY) |
|---|
|
$ 31.11 - 33.54 ( +/- 3.75%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-01 | Anevski Peter | Sell | 7 977 | Common Stock |
| 2024-04-01 | Schlanger David J | Sell | 1 000 | Stock Option (Right to Buy) |
| 2024-04-01 | Schlanger David J | Buy | 1 000 | Common Stock |
| 2024-04-01 | Schlanger David J | Sell | 2 681 | Common Stock |
| 2024-04-01 | Schlanger David J | Sell | 1 000 | Common Stock |
| INSIDER POWER |
|---|
| 6.44 |
| Last 100 transactions |
| Buy: 1 507 627 | Sell: 1 384 727 |
Forecast:
13:33 - $32.55
Live Trading Signals (every 1 min)
Forecast
1: 12:03 - $32.32
Forecast 2: 12:53 - $32.41
Forecast 3: 13:33 - $32.55
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $32.34 (-0.79% ) |
| Volume | 0.190 mill |
| Avg. Vol. | 0.846 mill |
| % of Avg. Vol | 22.47 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PGNY
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $40.32 | N/A | Active |
|---|
PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Latest Press Releases
2024-04-17 09:23:00 - Press Release
Progyny And Fertility Matters Canada Recognize Canadian Fertility Awareness Week To Advocate For Expanded Access To Family Building Care
The organizations will host an event with canada's leading providers, employers, and fertility advocates to show support for the millions in need of family building care the organizations will host an event with canada's leading providers, employers, and fertility advocates to show support for the millions in need of family building care
2024-04-04 08:59:00 - Press Release
Progyny And Resolve To Honor National Infertility Awareness Week® With Events Spanning Coast To Coast
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges the leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges
2024-03-18 12:00:00 - Press Release
Progyny, Inc. To Present At Keybanc Life Sciences & Medtech Investor Forum
New york, march 18, 2024 (globe newswire) -- progyny, inc. (nasdaq: pgny), a transformative fertility, family building, and women's health benefits solution, today announced that pete anevski, progyny's chief executive officer, and mark livingston, chief financial officer, will participate in a virtual fireside chat at the keybanc life sciences & medtech investor forum on tuesday, march 19, 2024, at 1:30 p.m. eastern time.
2024-03-11 12:00:00 - Press Release
Progyny, Inc. To Present At Barclays 26th Annual Global Healthcare Conference
New york, march 11, 2024 (globe newswire) -- progyny, inc. (nasdaq: pgny), a transformative fertility, family building, and women's health benefits solution, today announced that pete anevski, progyny's chief executive officer, and michael sturmer, progyny's president, will participate in a fireside chat at barclays 26th annual global healthcare conference on tuesday, march 12, 2024 at 10:15 a.m. eastern time.
2024-02-29 07:30:00 - Press Release
Progyny, Inc. Announces Share Repurchase Program
New york, feb. 29, 2024 (globe newswire) -- progyny, inc. (nasdaq: pgny), a transformative fertility, family building, and women's health benefits solution, announced today that its board of directors has approved a share repurchase program to repurchase up to $100 million of its common stock. the program will be funded through available cash balances.
Latest News
2024-04-05 20:29:48 - CNBC Television
Jim Cramer lays out his top small-cap healthcare picks
2024-03-18 12:00:00 - GlobeNewsWire
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 1:30 P.M. Eastern Time.
2024-03-15 14:33:39 - CNBC
This overlooked corner of women's health could be a $350 billion market opportunity
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
2024-03-15 12:12:42 - Seeking Alpha
Progyny: Long-Term Outlook Remains Positive, Reiterate Buy
Progyny, Inc. (PGNY) is recommended as a buy due to its potential for continued growth and positive long-term outlook. The recent weak share price is attributed to expected weak performance in 1Q24, but this is believed to be a temporary issue. PGNY's active pipeline is the largest it has ever been, indicating future growth opportunities, particularly in the women's health vertical.
2024-03-13 16:30:00 - InvestorPlace
The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024
Wagering on mid-cap stocks can potentially unlock investment treasures typically overlooked in the bustling market. Nestled between the giants and the upstarts, these stocks, with market capitalizations in the $2 billion to $10 billion range, offer a unique blend of growth potential and stability.
2024-03-11 12:00:00 - GlobeNewsWire
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chief Executive Officer, and Michael Sturmer, Progyny's President, will participate in a fireside chat at Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 10:15 A.M. Eastern Time.
2024-03-09 04:30:54 - Seeking Alpha
Progyny: Long-Term Thesis Still Intact
Progyny's stock is trailing the S&P 500 thus far in 2024 amongst macro concerns such as the Alabama court ruling on frozen embryos. However, Progyny's Q4 2023 revenue grew by 26%, and the company continues to add clients and increase the number of covered lives. With no debt and ample cash, the company authorized a share repurchase program up to $100 million.
2024-02-28 09:01:00 - Barrons
Progyny Stock Is Falling After Earnings. What the IVF Ruling Means for It.
Shares of fertility-solutions firm Progyny are in the red on disappointing guidance. The company says the Alabama court ruling on in vitro fertilization won't affect it.
2024-02-27 22:20:04 - Seeking Alpha
Progyny, Inc. (PGNY) Q4 2023 Earnings Call Transcript
2024-02-23 14:14:40 - InvestorPlace
Alabama's Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
This week brought another blow for reproductive rights in the U.S. An Alabama Supreme Court handed down a ruling that not only can frozen embryos be classified as “children,” but destroying them can lead to charges of wrongful death. This decision has prompted the University of Alabama at Birmingham, the state's largest healthcare provider, to cease all in vitro fertilization (IVF) treatments.